Quote:Special Counsel Gets Ready To Turn Trump’s People Against Him With Witness Flipping Expert
By Sarah Jones on Mon, Jun 19th, 2017 at 3:27 pm
As the Trump inner circle lawyers up and seeks advice from criminal lawyers, special counsel Robert Mueller has added a prosecutor to the Trump campaign probe who specializes in witness flipping.
Karen Freifeld of Reuters on Monday, “A veteran federal prosecutor recruited onto special counsel Robert Mueller’s team is known for a skill that may come in handy in the investigation of potential ties between Russia and U.S. President Donald Trump’s 2016 campaign team: persuading witnesses to turn on friends, colleagues and superiors.”
Andrew Weissmann’s addition was noted in early June, but Reuters pointed out that he specializes in witness flipping, “Andrew Weissmann, who headed the U.S. Justice Department’s criminal fraud section before joining Mueller’s team last month, is best known for two assignments – the investigation of now-defunct energy company Enron and organized crime cases in Brooklyn, New York – that depended heavily on gaining witness cooperation.”
Weissmann is another organized crime expert, who tried more than 25 cases involving organized crime families such as the Genovese, Colombo and Gambino families, as well as fighting the infiltration of organized crime on Wall Street.
Weissmann was a partner at Jenner & Block in New York for five years and co-chair of the firm’s White Collar Practice Group, where he worked on among other issues, the Foreign Corrupt Practices Act.
The team also includes white-collar crime expert Jeannie Rhee, former senior counselor in the DOJ’s National Security Division specializing in cybersecurity Aaron Zebley, former assistant special prosecutor for the Watergate probe James Quarles, and criminal law expert Michael Dreeben..
Part of any good investigation into criminal activity involves putting pressure on the targets through various means to get them to talk. Pressure can include leaking stories to the press floating ideas about who is being investigated and dropping stories that they asked for immunity possibly so they can flip on colleagues and friends.
These tactics serve to put pressure on the target, getting them to talk — hypothetically say, on the phone or over email or in a bugged office. The talking is what opens the flood gates.
President Trump doesn’t appear to require any pressure to stir up his already piqued paranoia, and he talks without compunction or care on Twitter, against legal advice.
But it can’t be helping Trump to know that Mueller has added a witness flipping expert to the team. Retired General Mike Flynn already asked the Senate Intelligence Committee for immunity and was denied. Perhaps he was denied because he wasn’t willing to give them what they wanted, or perhaps he was denied because they want to collect Flynn’s testimony first and keep their options open.
This is called applying pressure to see what it produces. It’s no wonder Trump wants to “fire” Mueller (something he can’t actually do, but we all know that won’t stop the President who could get around this technicality with more interference in the investigation) – Mueller is building a team only a fool wouldn’t be worried about.
Special Counsel Gets Ready To Turn Trump’s People
Top 10 Most Recent News Articles
UWM Faces Class Action Deadline: Key Insights for Investors
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Trial Disappointment: No Significant Gains in NSCLC
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue ReadingTop 5 Most Recently Viewed Articles
AIP Realty Trust Announces Successful Non-Brokered Offering
AIP Realty Trust's Financial Milestone Achieved AIP Realty Trust has made waves in the investment community by successfully finalizing the initial tranche of a significant non-brokered private placement. These efforts have brought in an impressive total of 7,260,000 Preferred Units—Series B Convertible, valued at US$0.50 each, resulting in gross proceeds of...
Continue Reading
Medtronic's BrainSense™ Receives CE Marking for Parkinson's Care
Medtronic’s Innovative Approval for Parkinson's Treatment Medtronic plc (NYSE: MDT), a global leader in healthcare technologies, has achieved a significant milestone by receiving CE Mark approval for its BrainSense™ Adaptive deep brain stimulation (aDBS) system and the BrainSense™ Electrode Identifier (EI). This remarkable advancement introduces the world's first...
Continue Reading
Understanding the New Rating for abrdn Asia-Pacific Income Fund
KBRA's Rating Insights on abrdn Asia-Pacific Income Fund Recently, KBRA has taken significant steps by assigning a new rating to the Series B Mandatory Redeemable Preferred Shares (MRPS) of abrdn Asia-Pacific Income Fund, Inc. (NYSE: FAX). This rating stands at 'AA-', illustrating the organization's confidence in the stability and security of these investment instruments....
Continue Reading
Protect Your Investment: Join the Applied Therapeutics Class Action
Understanding the Class Action for Applied Therapeutics Investors As an investor in Applied Therapeutics, Inc. (APLT), you may have felt the financial impact of recent challenges the company has encountered. The firm is currently facing a class action lawsuit aimed at addressing securities fraud that adversely affected investors between specific dates. This situation is...
Continue Reading
Heritage Capital Group Facilitates Mittauer's Strategic Sale
Heritage Capital Group Facilitates Mittauer's Strategic Sale Heritage Capital Group, Inc. ("Heritage"), a respected investment banking and financial advisory firm known for serving middle-market and emerging growth companies, has successfully guided its client, Mittauer & Associates, Inc. ("Mittauer"), through a significant transition in its business landscape. This...
Continue Reading